VTAK Plunges 13.18% Amid Reverse Split, UK Approval

On August 19, 2025, Catheter Precision experienced a significant drop of 13.18% in pre-market trading.

Catheter Precision, Inc. (VTAK) recently underwent a 1 for 19 reverse stock split, which means shareholders now hold 1 share for every 19 shares previously held. This corporate action is likely to have contributed to the recent volatility in the stock's price.

The company's LockeT device received approval for the UK market, which initially drove significant gains in the stock price. However, the approval did not translate into sustained positive momentum, as the company continues to face financial and operational challenges.

Catheter Precision has disclosed material weaknesses in its internal control and a history of losses, indicating that the company may need to raise additional funds to continue operations. These disclosures have likely weighed on investor sentiment, contributing to the recent decline in the stock price.